Chiarle R - Search Results

1

Wiskott-Aldrich syndrome protein (WASP) is a tumor suppressor in T cell lymphoma.

Menotti M, Ambrogio C, Cheong TC, Pighi C, Mota I, Cassel SH, Compagno M, Wang Q, Dall'Olio R, Minero VG, Poggio T, Sharma GG, Patrucco E, Mastini C, Choudhari R, Pich A, Zamo A, Piva R, Giliani S, Mologni L, Collings CK, Kadoch C, Gambacorti-Passerini C, Notarangelo LD, Anton IM, Voena C, Chiarle R. Menotti M, et al. Among authors: chiarle r. Nat Med. 2019 Jan;25(1):130-140. doi: 10.1038/s41591-018-0262-9. Epub 2018 Dec 3. Nat Med. 2019. PMID: 30510251 Free PMC article.

2

Argyrophilic nucleolar organizer region counts predict survival in thymoma.

Pich A, Chiarle R, Chiusa L, Palestro G. Pich A, et al. Among authors: chiarle r. Cancer. 1994 Sep 1;74(5):1568-74. doi: 10.1002/1097-0142(19940901)74:5<1568::aid-cncr2820740512>3.0.co;2-r. Cancer. 1994. PMID: 7520349

3

p53 expression and proliferative activity predict survival in non-invasive thymomas.

Pich A, Chiarle R, Chiusa L, Ponti R, Geuna M, Palestro G. Pich A, et al. Among authors: chiarle r. Int J Cancer. 1996 Jun 21;69(3):180-3. doi: 10.1002/(SICI)1097-0215(19960621)69:3<180::AID-IJC5>3.0.CO;2-W. Int J Cancer. 1996. PMID: 8682584 Free article.

4

Cell proliferation, bcl-2, c-myc, p53 and apoptosis as indicators of different aggressiveness in small lymphocytic lymphoma (SLL).

Palestro G, Ponti R, Chiusa L, Chiarle R, Geuna M, Novero D, Freilone R, Pich A. Palestro G, et al. Among authors: chiarle r. Eur J Haematol. 1997 Sep;59(3):148-54. doi: 10.1111/j.1600-0609.1997.tb00968.x. Eur J Haematol. 1997. PMID: 9310122

5

Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death.

Zamo A, Chiarle R, Piva R, Howes J, Fan Y, Chilosi M, Levy DE, Inghirami G. Zamo A, et al. Among authors: chiarle r. Oncogene. 2002 Feb 7;21(7):1038-47. doi: 10.1038/sj.onc.1205152. Oncogene. 2002. PMID: 11850821

6

In vivo interference with Skp1 function leads to genetic instability and neoplastic transformation.

Piva R, Liu J, Chiarle R, Podda A, Pagano M, Inghirami G. Piva R, et al. Among authors: chiarle r. Mol Cell Biol. 2002 Dec;22(23):8375-87. doi: 10.1128/MCB.22.23.8375-8387.2002. Mol Cell Biol. 2002. PMID: 12417738 Free PMC article.

7

NPM-ALK transgenic mice spontaneously develop T-cell lymphomas and plasma cell tumors.

Chiarle R, Gong JZ, Guasparri I, Pesci A, Cai J, Liu J, Simmons WJ, Dhall G, Howes J, Piva R, Inghirami G. Chiarle R, et al. Blood. 2003 Mar 1;101(5):1919-27. doi: 10.1182/blood-2002-05-1343. Epub 2002 Nov 7. Blood. 2003. PMID: 12424201 Free article.

8

Stat3 is required for ALK-mediated lymphomagenesis and provides a possible therapeutic target.

Chiarle R, Simmons WJ, Cai H, Dhall G, Zamo A, Raz R, Karras JG, Levy DE, Inghirami G. Chiarle R, et al. Nat Med. 2005 Jun;11(6):623-9. doi: 10.1038/nm1249. Epub 2005 May 15. Nat Med. 2005. PMID: 15895073

9

New and old functions of STAT3: a pivotal target for individualized treatment of cancer.

Inghirami G, Chiarle R, Simmons WJ, Piva R, Schlessinger K, Levy DE. Inghirami G, et al. Among authors: chiarle r. Cell Cycle. 2005 Sep;4(9):1131-3. doi: 10.4161/cc.4.9.1985. Epub 2005 Sep 30. Cell Cycle. 2005. PMID: 16082218 Review.

10

p130Cas mediates the transforming properties of the anaplastic lymphoma kinase.

Ambrogio C, Voena C, Manazza AD, Piva R, Riera L, Barberis L, Costa C, Tarone G, Defilippi P, Hirsch E, Boeri Erba E, Mohammed S, Jensen ON, Palestro G, Inghirami G, Chiarle R. Ambrogio C, et al. Among authors: chiarle r. Blood. 2005 Dec 1;106(12):3907-16. doi: 10.1182/blood-2005-03-1204. Epub 2005 Aug 16. Blood. 2005. PMID: 16105984 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

155 results

Search Page